Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-002591
Filing Date
2021-02-09
Accepted
2021-02-09 15:08:19
Documents
1
Period of Report
2021-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 24992
  Complete submission text file 0001567619-21-002591.txt   28566
Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Fund VIII, L.P. (Reporting) CIK: 0001618788 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 21605881

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 21605880

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Surplus Fund VIII, L.P. (Reporting) CIK: 0001628048 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 21605882

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 650-688-0818
Vivo Opportunity Fund, L.P. (Reporting) CIK: 0001726403 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 21605884

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Opportunity, LLC (Reporting) CIK: 0001728970 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39926 | Film No.: 21605883

Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Issuer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations